Skip to main content

Peer Review reports

From: The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma

Original Submission
27 Nov 2008 Submitted Original manuscript
22 Jan 2009 Reviewed Reviewer Report - Qing Ren
23 Jan 2009 Reviewed Reviewer Report - Richard Yaacov Lawrence
6 May 2009 Reviewed Reviewer Report - David Stokoe
5 Jul 2009 Author responded Author comments - Wantao Chen
Resubmission - Version 2
5 Jul 2009 Submitted Manuscript version 2
5 Jul 2009 Author responded Author comments - Wantao Chen
Resubmission - Version 3
5 Jul 2009 Submitted Manuscript version 3
22 Jul 2009 Reviewed Reviewer Report - David Stokoe
27 Jul 2009 Reviewed Reviewer Report - Richard Yaacov Lawrence
5 Aug 2009 Reviewed Reviewer Report - Qing Ren
18 Aug 2009 Author responded Author comments - Wantao Chen
Resubmission - Version 4
18 Aug 2009 Submitted Manuscript version 4
18 Sep 2009 Author responded Author comments - Wantao Chen
Resubmission - Version 5
18 Sep 2009 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
22 Sep 2009 Author responded Author comments - Wantao Chen
Resubmission - Version 7
22 Sep 2009 Submitted Manuscript version 7
Publishing
25 Sep 2009 Editorially accepted
25 Sep 2009 Article published 10.1186/1471-2407-9-343

You can find further information about peer review here.

Back to article page